Study rationale and design of a study of EMPAgliflozin's effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial
Gohari, Sepehr, Reshadmanesh, Tara, Khodabandehloo, Hadi, Fathi, Mojtaba, Ahangar, Hassan, Arsang-Jang, Shahram, Ismail-Beigi, Faramarz, Ghanbari, Samin, Dadashi, Mohsen, Muhammadi, Muhammad Javad, Gohari, Sheida, Ghaffari, Saeid
Published in BMC cardiovascular disorders (30.06.2021)
Published in BMC cardiovascular disorders (30.06.2021)
Get full text
Journal Article